HORUS PHARMA
LIVE

Serial Number

79128753

Owner

HORUS PHARMA

Attorney

G MATHEW LOMBARD

Filing Date

Jan 15, 2013

Add to watchlist:

No watchlists yet
View on USPTO

HORUS PHARMA Trademark

Serial Number: 79128753 • Registration: 4669091

HORUS PHARMA is a trademark filed by HORUS PHARMA on January 15, 2013. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

HORUS PHARMA (11 trademarks)

22 allée Camille Muffat

Entity Type: 99

Trademark Details

Filing Date

January 15, 2013

Registration Date

January 13, 2015

Published for Opposition

October 28, 2014

Cancellation Date

January 16, 2023

Goods & Services

Contact lenses; pupillometers for measuring pupillary distance and eye position in the spectacle frame by digital capture of corneal reflections and for measuring lens/eye distance not for medical use; video pupillometers for measuring pupillary distance and eye position in the spectacle frame by digital capture of corneal reflections and for measuring lens/eye distance not for medical use

Pharmaceutical and veterinary products and preparations for the treatment of ophthalmological and dermatological diseases; pharmaceutical and veterinary products and preparations for the treatment of allergies, glaucoma, inflammation, infections, viral diseases and conditions, keratoconjunctivitis sicca, dry eyes, and dermatological diseases and conditions; pharmaceutical and veterinary products and preparations for the promotion of ocular wound healing; chemical preparations for medical or pharmaceutical use, namely, chemical preparations for treatment of diseases, disorders and conditions of the eye and the skin; ophthalmic substances for medical use; food for babies; food and nutritional supplements for humans and animals for medical use; ophthalmic food, namely, dietary and nutritional supplements for eye and skin health and nutritional supplements for medical use; medical plasters, materials for dressings, namely, medical dressing; disinfectants, namely, all-purpose disinfectants; fungicides; solutions for contact lens care; eye drops for lubricating and moisturizing compositions and substances intended to relieve dryness and mild irritations of the eye; eye solutions for medical use, namely, irrigating, lubricating, rewetting and antibiotic solutions for eye care; eye washes; sanitary products for use in medicine, namely, sanitary preparations for medical use; sanitary preparations for medical ophthalmic use; creams, gels and lotions for ophthalmic use for medical use; cleansing medicinal creams, gels and lotions for soothing and decongesting the eyes and eye contours for medical use; eye solutions for medical use, namely, irrigating, lubricating, rewetting and antibiotic solutions for eye care; compresses for medical use, namely, surgical and medicated compresses; cotton for medical use; medicated bath preparations

Soaps for personal use; essential oils; cosmetics; hair lotions; dentifrices

Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in eye surgery, ophthalmic surgery; medical and veterinary apparatus and instruments, namely, pupillometers; apparatus and instruments for ophthalmology, namely, surgical apparatus and instruments for use in ophthalmic surgery, instruments for measuring the diameter of ophthalmic lenses, instruments for measuring the optical density of the macular pigment, instruments for measuring, recording and monitoring intraocular pressure, instruments for measuring and recording pupillary reactivity and pupillary distance, and instruments for dyeing and removing vitreous bodies and epiretinal membranes during vitrectomies; artificial limbs and eyes; ocular implants made from artificial materials; orthopedic articles, namely, ocular implants made of artificial materials, ocular and ophthalmic inserts for medical or surgical use, namely, intraocular implants made of artificial materials, inserts for ocular and intraocular use, namely, intraocular implants made of artificial materials; suture materials

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 6, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 6, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 8, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 13, 2022 INTS
INVALIDATION PROCESSED
Jul 13, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 30, 2022 INTR
CANCELLED SECTION 71
Jul 30, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 13, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 20, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 22, 2015 FICS
FINAL DISPOSITION PROCESSED
May 22, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 13, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2015 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2014 TCCA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 30, 2014 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 28, 2014 NPUB
PUBLISHED FOR OPPOSITION
Oct 28, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Oct 23, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 15, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 15, 2014 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 8, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 8, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 23, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 22, 2014 ERSI
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 12, 2014 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 9, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 9, 2014 GNSL
SUSPENSION LETTER WRITTEN
Apr 9, 2014 CNSL
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 9, 2014 ZZZX
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Apr 9, 2014 PBER
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2013 CRFA
ASSIGNED TO LIE
Aug 9, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2013 TROA
REFUSAL PROCESSED BY IB
Jun 5, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 13, 2013 RFCS
REFUSAL PROCESSED BY MPU
May 13, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 11, 2013 RFCR
NON-FINAL ACTION WRITTEN
May 10, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
May 7, 2013 MAFR
ASSIGNED TO EXAMINER
May 3, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2013 REPR